Stability of Nine Time-Dependent Antibiotics for Outpatient Parenteral Antimicrobial Therapy (OPAT) Use
- PMID: 40426533
- PMCID: PMC12108229
- DOI: 10.3390/antibiotics14050466
Stability of Nine Time-Dependent Antibiotics for Outpatient Parenteral Antimicrobial Therapy (OPAT) Use
Abstract
Background: The use of an elastomeric diffuser is favored to administer outpatient antibiotic therapy. A study published in 2022 highlighted the instability of several antibiotics in elastomeric devices at 37 °C. The objective was to evaluate the stability of nine time-dependent antibiotics that are unstable at 37 °C at lower concentrations and a reduced storage temperature of 32 °C. Methods: Chemical stability was assessed by pH measurement and high-performance liquid chromatography. Physical stability was evaluated by visual and subvisual inspection. The solutions were considered stable if the remaining drug percentage was ≥90%, the maximum variation in pH was less than 1, the particle count was within acceptable limits and the visual aspect remained unchanged after storage. Results: Solutions showing stability for 24 h are composed of 12.5 mg/mL cefiderocol in NS (normal saline) and 50-133 mg/mL piperacillin in NS-D5W (5% dextrose). Additionally, 12.5 mg/mL amoxicillin in NS; 12.5 mg/mL cefepime in NS-D5W; 12.5 mg/mL cefiderocol in D5W; 25 mg/mL cefiderocol in NS-D5W; 12.5 mg/mL cefotaxime in NS-D5W; 12.5 mg/mL cefoxitin in NS-D5W; 12.5 mg/mL ceftazidime in NS-D5W; 25 mg/mL ceftazidime in NS; 25 mg/mL cloxacillin in NS-D5W; and 25-50 mg/mL oxacillin in NS were shown to be stable for 12 h. Notably, 25 mg/mL amoxicillin in NS, 50 mg/mL cloxacillin in NS and 25 mg/mL oxacillin in D5W were shown to be stable for 8 h. Conclusions: These 12-24 h stability data indicate that these antibiotics can be administered by continuous infusion using only one-two elastomeric devices per day, facilitating outpatient parenteral antimicrobial therapy (OPAT).
Keywords: antibiotic; elastomeric diffuser; outpatient parenteral antimicrobial therapy; stability.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Norris A.H., Shrestha N.K., Allison G.M., Keller S.C., Bhavan K.P., Zurlo J.J., Hersh A.L., Gorski L.A., Bosso J.A., Rathore M.H., et al. 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy. Clin. Infect. Dis. 2019;68:e1–e35. doi: 10.1093/cid/ciy745. - DOI - PubMed
-
- Loeuille G., D’Huart E., Vigneron J., Nisse Y.E., Beiler B., Polo C., Ayari G., Sacrez M., Demoré B., Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics. 2022;11:458. doi: 10.3390/antibiotics11040458. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous